Consider augmentation or switching strategies when first-line antidepressants are unsuccessful in major depressive disorder

Author：  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.27, Iss.12, 2011-12, pp. : 7-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomic Analysis of Antidepressants for Major Depressive Disorder in the United Kingdom

By Freeman H.  

PharmacoEconomics, Vol. 18, Iss. 2, 2000-08 ,pp. : 143-148

Adis International

Access to resources Recommend Favorite

Augmentation of Citalopram with Aspirin for Treating Major Depressive Disorder, a Double Blind Randomized Placebo Controlled Clinical Trial

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 13, Iss. 2, 2014-08 ,pp. : 108-111

Bentham Science Publishers

Access to resources Recommend Favorite

Vilazodone: In Major Depressive Disorder

By Frampton James E.  

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 615-627

Adis International

Access to resources Recommend Favorite

Aripiprazole: In Major Depressive Disorder

By Weber Juliane   Lyseng-Williamson Katherine A.   Scott Lesley J.  

CNS Drugs, Vol. 22, Iss. 10, 2008-01 ,pp. : 807-813

Adis International

Access to resources Recommend Favorite

If at First You Don't Succeed: A Review of the Evidence for Antidepressant Augmentation, Combination and Switching Strategies

By Connolly K. Ryan   Thase Michael E.  

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 43-64

Adis International

Access to resources Recommend Favorite